Open AccessSystematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis
Author(s) -
Edo Savelkoul,
Pepijn W. A. Thomas,
Lauranne Derikx,
Nathan den Broeder,
Tessa E H Römkens,
Frank Hoentjen
Publication year - 2022
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izac200
Subject(s) - adalimumab , infliximab , medicine , ulcerative colitis , confidence interval , gastroenterology , tumor necrosis factor alpha , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom